Detalles de la búsqueda
1.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625938
2.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809405
3.
Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis.
JCO Precis Oncol
; 7: e2300051, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856765
Resultados
1 -
3
de 3
1
Próxima >
>>